RE:RE:RE:DESPERATE BASHINGOk here's the dream.
1) Tripp halts the stock and news comes out that an agreement has been made or letter of understanding from Blue Cross/Blue Shield that they have approved the test for their members.
2) A week later Tripp halts and announces Aristotle is fully commercialized and avaiable to all
3) Tripp announces a national deal with numerous first responders/fire fighter associations to be tested
4) Tripp announces medicare/medicaid and others will fully fund the test
NoGambleNoFutur wrote: I understand that many of us are waiting for SZLS to announce partnerships, but in my personal opinion, I think that's going to be the easiest point moving forward. When they release Aristotle, which is one of the first multi-cancer screening tests to become available on the market, I think they'll be able to close some valuable partnerships. I just want all of you to realize something quite important though. I feel like this industry in general can only be successful if employers include this type of testing in employee's benefits/insurance plans. Ask anyone around you, everyone would love to do this type of test, but the moment you mention that it's $300 USD, you're narrowing the amount of buyers by a substantial amount. If you found out that your insurance plan covers 90% of this test, everyone would be inclided to do it. I can't see this industry being extremely succesful unless it's covered by insurance. I'm obviously taking a gamble on the fact that it will in the future.